This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group and an amine functionality, makes it valuable in the development of drugs targeting central nervous system disorders, such as antidepressants and antipsychotics. The chiral nature of the compound is particularly important in creating enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Additionally, it is employed in research and development for exploring new therapeutic agents, particularly in the field of medicinal chemistry where fluorine-containing compounds are of significant interest due to their unique pharmacokinetic properties.